Tag Archive for: U.K. Health Protection Agency

NanoBio and the U.K. Health Protection Agency Awarded Up to $24 Million to Develop an Intranasal Anthrax Vaccine

ANN ARBOR, Mich. (December 1, 2012) – NanoBio® Corporation announced today that it is partnering with the U.K.-based Health Protection Agency (HPA) to develop an intranasal anthrax vaccine for the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). Read more